Member Info for nomlungu

I am one of the 'foot soldiers' who withdrew from the frontline to keep my powder dry - until the fallout from the Brexit fog dissipates and funding reassurance emmerges, I am compelled to remain in the watchtower.

Looking forward to the next placing or the next news about the mythical NASDAQ IPO?

Hopefully not forward selling - there will be some annoyed people if the rise proves to be indicative of another placing.

jl5006,

I know ... They provide / monetise some of the infrastructure to deliver the utilities we cannot live without.

The potential dividend yield / growth outlook looked worthwhile to me at the current price - time will tell how good my timing is.

WorldGoRound,

Was the meths drinker using bread to get the dye out? They self-combust when they go outside to smoke...

Bit like DEB's share price at the moment?

So have put a small limit order in for today at 33.51... We cannot live without Utilities.

I was surprised that the Ask had increased, so checked what Best Invest are quoting - 0.62p for £5000 a few minutes ago (much to my surprise).

I expect the price to be closer to £1 today.

17 bagger today? Surely that may be a little optimistic.

An interesting approach using machine learning - could have a major [negative] effect on bios in the future:

http://cancerres.aacrjournals.org/content/79/7/1671.full

A bit like DeepMind' Alphafold

https://deepmind.com/blog/alphafold/

Interesting for maths geeks

Some may find the article below interesting, as well as the comments about the article on the Y_Combinator news page:

http://cancerres.aacrjournals.org/content/79/7/1671.full

https://news.ycombinator.com/item?id=19550028

The Author states: 'In this study, we compare immune receptor sequences from tumor tissue to adjacent healthy tissue. Using "Multiple Instance Learning" we perform machine learning on the sets of immune receptor sequences to identify immune receptors that may be involved in the cancer response.'

Lyft has done badly today

https://www.koyfin.com/charts/gip/LYFT

https://news.ycombinator.com/news can be an interesting news feed..

A share I have an interest in - good news today - $5m 2019 drilling program into a Zinc resource funded by Ascendant [TSE: ASND]

Well done for filtering me Freddy and ValJu.

Why not try and find errors in my logic? Filtering me will not stop me posting my opinions even if you find them discomfortable.

Postscript: Freddy argued some time ago that Valiseek was ASX: SEK which has a significant market capitalisation.

I do not attend Investor Roadshows about AIM shares [ie - please can we have more money to progress whilst we dilute existing shareholders]. Without details being announced by an RNS I am sceptical even though trading opportunities can result.

But I do take note of the Companies who present as they often are trying to get attention from potential new investors, who often buy in after placings are announced.

I have previously stated that the only way that the only way to profit from a small-cap biotech company is to register with the broker, participate in future placings and hope to flip the shares to get a small free carry \ modest profitable trade. Whilst I have never personally heard the comment about second hand shareholders, the phrase makes some sense to me.

I stand by my opinion and continue to pay little credence to comments posted by people who have become emotionally involved in a share.

Nonetheless, I would prefer private investors to profit. However, the share price chart over the last year and a half seems to paint a bleaker picture than most here seem to be prepared to acknowledge.

Deep fried investors? The 3 month chart does not look good and details of the recapitalisation are still waited for.

So many positive comments over the weekend suggesting 4p today and yet the share price is down - has some of the risk been transferred to private investors who cannot afford to keep buying in / averaging down?

zanmantate,

There are further staged payments due if Ascendant continue paying for further drilling in the years to come. I do not have the figures to hand now, but will have a look during the week and might post my research over the weekend.

As your post on Sunday shows, the rest of the portfolio seems to be doing quite well. Pumpedordumped data seems to show that the market makers have little stock and there is currently a small spread. Spring has come and hopefully the share price will soon reflect the rosy future that seems to await MAFL.

http://pumpedordumped.com/prices/price.php?latest=mafl

States:

Ascendant may increase its ownership to 50% by investing US$9.0 million within 48 months and paying TH Crestgate US$3.5 million.

Today's RNS stating the commitment of $5.2M for 2019 bodes well for the future.

ValJu - you state:

'Good to see Valiseek now self funding, yes, allowing for Valirx to receive income by way of royalties and/or lump sum, to enable further development of 201, 101 and 301.'

Whilst they have letters of intent from 2 parties that does not mean that legally binding contracts have been entered into. There is no certainty that Valiseek will receive any royalties or lump sums let alone Valirx receiving any dividends from Valiseek.

If legally binding contracts iro Valiseek do occur any royalties would be on sales after the drug is approved, which would be a number of years time. Any lump sums received by Valiseek could end up being used by them for their R&D and Admin costs (£356k according to the last accounts on Companies House) or towards any costs that they may be required to pay - the phrase used in the last RNS is 'on a co-financing basis'. A bit ambiguous - are the 2 partners who signed the LOI going to be sharing the costs themselves or is Valiseek going to have to raise funds as a party to co-financing which could see Valirx's share being diluted?

Nonetheless, thank you for taking the time to attend the presentation and providing your detailed update.